Prostate disease risk factors among a New Zealand cohort.
about
The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysisQuality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?Two common functional catalase gene polymorphisms (rs1001179 and rs794316) and cancer susceptibility: evidence from 14,942 cancer cases and 43,285 controls.Selenium and chronic diseases: a nutritional genomics perspective.A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet.The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of CancersInfluence of Gender and SNPs in GPX1 Gene on Biomarkers of Selenium Status in Healthy Brazilians.The rs1050450 C > T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Association of Catalase and Glutathione Peroxidase 1 Polymorphisms with Chronic Hepatitis C Outcome.SNP-SNP interactions as risk factors for aggressive prostate cancer.Genetic Polymorphism of CAT C-262 T and Susceptibility to Breast Cancer, a Case-Control Study and Meta-Analysis of the Literatures.Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.
P2860
Q28081117-E7D69546-7006-4D6F-9993-F4BACD891743Q28385758-7C03456E-404F-4B06-BE46-95A72D13F6ACQ30360505-62CF976A-2333-482A-9A7D-35A4CE9E3F41Q35658168-E3D69CDD-A495-4141-9BFD-69FFDADA00EFQ35824866-3EAE39A6-D376-4FCC-BFBD-DB32760A6716Q36937396-F06859E5-246F-4A60-ADC0-CD8EB68E4730Q36941671-601E42EE-A57A-45DD-9C92-180E5B52BB4DQ38405393-B17618E7-92E2-434B-8BFC-C85BEC78F318Q40311743-9691708E-75B7-486C-A9F5-1B62ABEB3425Q40750510-E26E08EF-9DDE-466C-885C-66458804A90BQ42054665-22A9DD69-9351-4D29-BE33-6C588A7C80C2Q51111503-E6DA1ED9-76FA-4158-974D-6A0A2F547F56Q51804729-C7E52775-6C16-4517-B62F-7C0355584CB0Q53791912-A8016487-1EEE-41C7-A5B2-78D6C65EFBAD
P2860
Prostate disease risk factors among a New Zealand cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prostate disease risk factors among a New Zealand cohort.
@en
Prostate disease risk factors among a New Zealand cohort.
@nl
type
label
Prostate disease risk factors among a New Zealand cohort.
@en
Prostate disease risk factors among a New Zealand cohort.
@nl
prefLabel
Prostate disease risk factors among a New Zealand cohort.
@en
Prostate disease risk factors among a New Zealand cohort.
@nl
P2093
P2860
P356
P1476
Prostate disease risk factors among a New Zealand cohort.
@en
P2093
Alice Wang
Dug Yeo Han
Jonathan Masters
Katja Lange
Lynnette R Ferguson
Megan Goudie
Roxanne Medhora
Shiu Theng Kan
P2860
P304
P356
10.1159/000346279
P577
2012-01-01T00:00:00Z